Predictors of 12‐Months Relapse After Withdrawal Treatment in Hospitalized Patients With Chronic Migraine Associated With Medication Overuse: A Longitudinal Observational Study
- 14 November 2016
- journal article
- research article
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 57 (1) , 60-70
Abstract
Background: Studies addressing relapse rates conflate relapse into chronic migraine (CM) and medication overuse (MO), and the consequent need to repeat withdrawal. We aim to identify 12‐months predictors of relapse into CM (based on headaches frequency) separately from occurrence of another structured withdrawal. Methods: Hospitalized patients with CM‐MO under withdrawal were enrolled. Candidate predictors included demographic, disability, quality of life, depression scores, general self‐efficacy, social support, headaches frequency and intensity, class of overused medications, history of withdrawal treatment in the three years prior to enrollment, attendance to emergency room (ER) between enrollment and follow‐up, nonattendance to outpatient neurological examinations. Logistic regressions was used to address the significant predictors for the two outcomes. Results: Complete data were available for 177 patients: 60 (33.9%) relapsed into CM, 38 (21.5%) underwent another withdrawal treatment. Recent history of withdrawal treatments, ER admission after discharge and high baseline BDI‐II scores were significant predictors in both models. In addition to this, high baseline headache frequency predicted relapse into another withdrawal treatment. Conclusions: Predictors or relapse into CM and of occurrence of another withdrawal by 12‐months are somehow similar. It is important to assess presence of recent previous withdrawal treatments and to plan regular follow‐up afterwards, in particular for patients with high headache frequency and relevant mood disturbances: in this way, it will be more likely that situations requiring further structured withdrawal treatments can be identified before patients have to refer to ER.Keywords
Funding Information
- Neurological Institute C. Besta IRCCS Foundation.
This publication has 37 references indexed in Scilit:
- The role of tyrosine metabolism in the pathogenesis of chronic migraineCephalalgia, 2013
- Is β endorphin related to migraine headache and its relief?Cephalalgia, 2013
- Treatment of medication overuse headache - guideline of the EFNS headache panelEuropean Journal of Neurology, 2011
- Migraine ChronificationCurrent Neurology and Neuroscience Reports, 2011
- Chronic Migraine: Epidemiology and Disease BurdenCurrent Pain and Headache Reports, 2010
- Global prevalence of chronic migraine: A systematic reviewCephalalgia, 2009
- Family History for Chronic Headache and Drug Overuse as a Risk Factor for Headache ChronificationHeadache: The Journal of Head and Face Pain, 2009
- Medication Overuse Headache: Predictors and Rates of Relapse in Migraine Patients With Low Medical Needs. A 1-Year Prospective StudyCephalalgia, 2008
- Acute Migraine Medications and Evolution From Episodic to Chronic Migraine: A Longitudinal Population‐Based StudyHeadache: The Journal of Head and Face Pain, 2008
- Medication-overuse headache: a worldwide problemThe Lancet Neurology, 2004